Biological assay of a novel quinoxalinone with antimalarial efficacy on Plasmodium yoelii yoelii

Parasitology Research

Volumn 112, Issue 4, 2013, Pages 1523-1527

  Rivera, Norma ^a   Ponce, Yovani Marrero ^b   Arán, Vicente J ^c   Martínez, Cecilia ^a   Malagón, Filiberto ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b CENTRAL UNIVERSITY OF LAS VILLAS   (Cuba)

^c INSTITUTO DE QUÍMICA MÉDICA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

1 METHYL 7 NITRO 4 [5 (PIPERIDIN 1 YL)PENTYL] 3,4 DIHYDROQUINOXALIN 2 (1H)ONE; ANTIMALARIAL AGENT; CHLOROQUINE; UNCLASSIFIED DRUG;

ACUTE TOXICITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIMALARIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG CYTOTOXICITY; DRUG EFFICACY; DRUG MEGADOSE; DRUG SCREENING; DRUG STRUCTURE; GROWTH INHIBITION; IN VIVO STUDY; LD 50; MALARIA; MALE; MOUSE; NONHUMAN; PARASITE IDENTIFICATION; PARASITEMIA; PLASMODIUM YOELII; PRIORITY JOURNAL; TOXICITY TESTING;

ADMINISTRATION, ORAL; ANIMALS; ANTIMALARIALS; BIOLOGICAL ASSAY; DISEASE MODELS, ANIMAL; MALARIA; MALE; MICE; PLASMODIUM YOELII; QUINOXALINES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

ANIMALIA; MUS; PLASMODIUM YOELII YOELII;

EID: 84876415006     PISSN: 09320113     EISSN: 14321955     Source Type: Journal    
DOI: 10.1007/s00436-013-3298-2     Document Type: Article

References (25)

1. Arora K, Srivastava AK (2005) Antimalarial efficacy of methylene blue and menadione and their effect on glutathione metabolism of Plasmodium yoelii-infected mice. Parasitol Res 97:521-526
2. Argotte RR, Ramírez AG, Rodríguez GMC et al (2006) Antimalarial 4-phenylcoumarins from the stem bark of Hintonia latiflora. J Nat Prod 69:1442-1444
3. Baird JK, Rieckmann KH (2003) Can primaquine therapy for vivax malaria be improved? Trends Parasitol 19(3):115-120
4. Becker DE (2006) Drug therapy in dental practice: general principles. Part 1 - pharmacokinetic considerations. Anesth Prog 53:140-146
5. Giha H (2010) Artemisinin derivatves for treatment of uncomplicated Plasmodium falciparum malaria in Sudan: too early for too much hope. Parasitol Res 106:549-552
6. Goulart HR, Kimura EA, Peres VJ et al (2004) Terpenes arrest parasite development and inhibit biosynthesis of isoprenoids in Plasmodium falciparum. Antimicrob Agents Chemoter 48:2502-2509
7. Höfle G, Bööhlendorf B, Fecker T, Sasse F, Kunze B (2008) Semisynthesis and antiplasmodial activity of the quinoline alkaloid aurachin. J Nat Prod 71(11):1967-1969
8. Jensen M, Mehlhorn H (2009) Seventy-five years of Resochin in the fight against malaria. Parasitol Res 105:609-627
9. Kaur K, Jain M, Reddy RP, Jain R (2010) Quinolines and structurally related heterocycles as antimalarials. Eur J Med Chem 45(8):3245-3264
10. Lorke D (1983) A new approach to practical acute toxicity testing. Arch Toxicol 54:275-287
11. Marrero-Ponce Y, Castillo GJ, Olazabal E et al (2004) TOMOCOMD-CARDD, a novel approach for computer-aided 'rational' drug design: I theoretical and experimental assessment of a promising method for computational screening and in silico design of new anthelmintic compounds. J of Computer-Aided Mol Des 18:615-634
12. Moneriz C, Marín-García P, Bautista JM, Diez A, Puyet A (2011) Parasitostatic effect of maslinic acid. II. Survival increase and immune protection in lethal Plasmodium yoelii-infected mice. Malar J 25:10-103
13. Montero A, García RN, Marrero-Ponce Y et al (2006) Non-stochastic quadratic fingerprints and LDA-based QSAR models in hit and lead generation through virtual screening: theoretical and experimental assessment of a promising method for the discovery of new antimalarial compounds. Eur J Med Chem 41:483-493
14. Muregi FW, Kirira PG, Ishih A (2011) Novel rational drug design strategies with potential to revolutionize malaria chemotherapy. Curr Med Chem 18(1):113-143
15. Murray CJL, Rosenfeld L, Lim SS et al (2012) Global malaria mortality between 1980 and 2010: a systematic analysis. Lancet 379:413-443
16. Peters W, Robinson BL (1992) The chemotherapy of rodent malaria. XLVII. Studies on pyronaridine and other Mannich base antimalarials. Ann Trop Med Parasitol 86(5):455-465
17. Qiu W-W, Shen Q, Yang F et al (2009) Synthesis and biological evaluation of heterocyclic ring-substituted maslinic acid derivatives as novel inhibitors of protein tyrosine phosphatase. Bioorg Med Chem Lett 19:6618-6622
18. Quéré L, Wenger R, Schramm HJ (1996) Triterpenes as potential dimerization inhibitors of HIV-1 protease. Biochem Biophys Res Commun 227:484-488
19. Rangisetty JB, Gupta CN, Prasad AL et al (2001) Synthesis of new arylaminoquinoxalines and their antimalarial activity in mice. J Pharm Pharmacol 53(10):1409-1413
20. Rivera O, Marrero-Ponce Y, Meneses A et al (2009) Discovery of novel trichomonacidals using lda-driven qsar models and bond-based bilinear indices as molecular descriptors. QSAR Com Sci 1:9-26
21. Schlitzer M (2008) Antimalarial drugs - what is in use and what is in the pipeline. Arch Pharm 341:149-163
22. Sharma A, Mishra NC (1999) Inhibition of a protein tyrosine kinase activity in Plasmodium falciparum by chloroquine. Indian J Biochem Biophys 36(5):299-304
23. Turner VP, Brabb T, Pekow C, Vasbinder M (2011) Administration of substances to laboratory animals: routes of administration and factors to consider. J Am Assoc Lab Anim Sci 50(5):600-613
24. Vega MC, Montero A, Marrero Y et al (2006) New ligand-based approach for the discovery of antitrypanosomal compounds. Bioorg Med Chem Lett 16:1898-1904
25. Zhang Y, Qi J, Li J et al (2012) A new antimalarial antigen produces partial protection against Plasmodium yoelii challenge. Parasitol Res 110:1337-1345